There were 26 serious adverse events in 19 participants; 21 (81%) occurred within 2 months after surgery. HealthDay News — In participants with geographic atrophy due to age-related macular ...
Please provide your email address to receive an email when new articles are posted on . Restoret activates Wnt in the retinal vasculature. Tiespectus is a Tie2 agonist that blocks VEGF. ORLANDO — Two ...
CureSight is one of a cluster of technologies emerging from Israeli startups that are reimagining amblyopia treatment from the ground up. Where patching shuts down one eye to train the other, these ...
Please provide your email address to receive an email when new articles are posted on . Distance BCVA improved significantly in patients treated with RevitalVision. Forty-six percent of treated ...
The Fast Track designation is supported by the ongoing randomized, double-masked phase 3 LYNX-2 trial. The Food and Drug Administration (FDA) has granted Fast Track designation to phentolamine ...